MedTrace Logo

Relationship Between HIV and Malaria in Ugandan Children

NCT00356824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-11-01

No results posted yet for this study

Summary

HIV and malaria are two of the most important diseases to afflict children in sub-Saharan Africa. However, it is unknown what relationships exist between the two diseases. The purpose of this study is to determine the relationship between HIV and malaria infections in HIV infected Ugandan children.

Conditions

Interventions

DRUG

Amodiaquine

200 mg oral tablet taken daily for 3 days under direct supervision at study clinic

DRUG

Artesunate

50 mg oral tablet taken daily for 3 days under direct supervision at study clinic

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Diane V. Havlir, MD · University of California, San Francisco and San Francisco General Hospital

  • Moses R. Kamya, MBChB, MMed, MPH · Department of Medicine, Makerere University, Kampala, Uganda

  • Rukyalekere-Adeodadata Kekitiinwa · Department of Pediatrics, Makerere University, Kampala, Uganda

  • Anne Gasasira · Makerere University Medical School, Makerere University, Kampala, Uganda

  • Israel Kalyesubula · Department of Pediatrics, Makerere University, Kampala, Uganda

  • Grant Dorsey · University of California, San Francisco

  • Edwin Charlebois · University of California, San Francisco

  • Philip Rosenthal · University of California, San Francisco

  • Huyen Cao · California Department of Human Services

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-04-30
Completion
2010-05-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00356824 on ClinicalTrials.gov